Bristol Myers Squibb sues Biden administration over Medicare drug negotiations

Bristol Myers Squibb connected Friday sued the Biden medication implicit Medicare's caller powers to negociate cause prices, the 3rd specified suit to beryllium filed against the programme successful a substance of days.

The lawsuit, filed successful national territory tribunal successful New Jersey, argues the Medicare negotiations interruption the First and Fifth Amendments of the U.S. Constitution.

Bristol Myers Squibb said its humor thinner Eliquis volition beryllium taxable to the negotiations this year. Eliquis is utilized to forestall humor clots and strokes.

The drugmaker has asked the tribunal to state the programme unconstitutional and forestall the Health and Human Services Department from forcing the institution to participate negotiations.

Bristol Myers Squibb's arguments reflector those lodged by drugmaker Merck past week, which was the archetypal institution to writer the national authorities implicit the cause negotiations.

The U.S. Chamber of Commerce has besides sued HHS implicit the programme with akin arguments.

This is breaking news. Please cheque backmost for updates.